Cargando…

Role of Phytoconstituents as PPAR Agonists: Implications for Neurodegenerative Disorders

Peroxisome proliferator-activated receptors (PPAR-γ, PPAR-α, and PPAR-β/δ) are ligand-dependent nuclear receptors that play a critical role in the regulation of hundreds of genes through their activation. Their expression and targeted activation play an important role in the treatment of a variety o...

Descripción completa

Detalles Bibliográficos
Autores principales:	, Sanjay, Sharma, Anshul, Lee, Hae-Jeung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698906/ https://www.ncbi.nlm.nih.gov/pubmed/34944727 http://dx.doi.org/10.3390/biomedicines9121914

Ejemplares similares

Roles of Fatty Acids in Microglial Polarization: Evidence from In Vitro and In Vivo Studies on Neurodegenerative Diseases
por: Sanjay,, et al.
Publicado: (2022)

Therapeutic Potential of Phytoconstituents in Management of Alzheimer's Disease
por: Singh, Anurag Kumar, et al.
Publicado: (2021)

Development of PPARγ Agonists for the Treatment of Neuroinflammatory and Neurodegenerative Diseases: Leriglitazone as a Promising Candidate
por: Pizcueta, Pilar, et al.
Publicado: (2023)

PPAR Agonists and Metabolic Syndrome: An Established Role?
por: Botta, Margherita, et al.
Publicado: (2018)

Role of phytoconstituents in the management of COVID-19
por: Das, Amiya, et al.
Publicado: (2021)

Elucidating the Beneficial Role of PPAR Agonists in Cardiac Diseases
por: Khuchua, Zaza, et al.
Publicado: (2018)

Stevia and Stevioside Attenuate Liver Steatosis through PPARα-Mediated Lipophagy in db/db Mice Hepatocytes
por: Park, Miey, et al.
Publicado: (2022)

The Novel Role of PPAR Alpha in the Brain: Promising Target in Therapy of Alzheimer’s Disease and Other Neurodegenerative Disorders
por: Wójtowicz, Sylwia, et al.
Publicado: (2020)

Ginsenoside Compound K: Insights into Recent Studies on Pharmacokinetics and Health-Promoting Activities
por: Sharma, Anshul, et al.
Publicado: (2020)

Anti-Inflammatory Activity of Bilberry (Vaccinium myrtillus L.)
por: Sharma, Anshul, et al.
Publicado: (2022)

The Role of PPARγ in the Transcriptional Control by Agonists and Antagonists
por: Tsukahara, Tamotsu
Publicado: (2012)

Role of PPARα and Its Agonist in Renal Diseases
por: Cheng, Ching-Feng, et al.
Publicado: (2010)

PPAR-γ Agonists and Their Role in Primary Cicatricial Alopecia
por: Harnchoowong, Sarawin, et al.
Publicado: (2017)

Phytoconstituents as photoprotective novel cosmetic formulations
por: Saraf, S., et al.
Publicado: (2010)

PPAR-γ Agonists and Their Effects on IGF-I Receptor Signaling: Implications for Cancer
por: Belfiore, A., et al.
Publicado: (2009)

Phytoconstituent-Loaded Nanofibrous Meshes as Wound Dressings: A Concise Review
por: Sharma, Ameya, et al.
Publicado: (2023)

AMPK-Dependent Metabolic Regulation by PPAR Agonists
por: Lee, Woo Hyung, et al.
Publicado: (2010)

Cataract Preventive Role of Isolated Phytoconstituents: Findings from a Decade of Research
por: Lim, Vuanghao, et al.
Publicado: (2018)

Emerging evidence implicating a role for neurexins in neurodegenerative and neuropsychiatric disorders
por: Cuttler, Katelyn, et al.
Publicado: (2021)

Peroxisome Proliferator-Activated Receptor (PPAR) γ and PPARα Agonists Modulate Mitochondrial Fusion-Fission Dynamics: Relevance to Reactive Oxygen Species (ROS)-Related Neurodegenerative Disorders?
por: Zolezzi, Juan M., et al.
Publicado: (2013)

PPAR Agonists and Cardiovascular Disease in Diabetes
por: Calkin, Anna C., et al.
Publicado: (2008)

Phospholipid Complex Technique for Superior Bioavailability of Phytoconstituents
por: Gnananath, Kattamanchi, et al.
Publicado: (2017)

PPARα Agonist Oral Therapy in Diabetic Retinopathy
por: Tomita, Yohei, et al.
Publicado: (2020)

Safety of PPAR Agonists
por: Home, Philip
Publicado: (2011)

A Review of Recent Studies on the Antioxidant Activities of a Third-Millennium Food: Amaranthus spp.
por: Park, Seon-Joo, et al.
Publicado: (2020)

Postbiotics against Obesity: Perception and Overview Based on Pre-Clinical and Clinical Studies
por: Park, Seon-Joo, et al.
Publicado: (2023)

Alkaloidal Phytoconstituents for Diabetes Management: Exploring the Unrevealed Potential
por: Behl, Tapan, et al.
Publicado: (2022)

PPARγ Agonists: Emergent Therapy in Endometriosis
por: Vallée, Alexandre, et al.
Publicado: (2021)

Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?
por: Scatena, Roberto, et al.
Publicado: (2008)

Carbon Dots for the Treatment of Inflammatory Diseases: An Appraisal of In Vitro and In Vivo Studies
por: Sharma, Anshul, et al.
Publicado: (2023)

Herbal Drugs from Sudan: Traditional Uses and Phytoconstituents
por: Karar, Mohamed Gamaleldin Elsadig, et al.
Publicado: (2017)

Cannabinoids: A New Group of Agonists of PPARs
por: Sun, Yan, et al.
Publicado: (2007)

PPARγ Agonists: Blood Pressure and Edema
por: Blazer-Yost, Bonnie L.
Publicado: (2010)

PPAR Agonists for the Prevention and Treatment of Lung Cancer
por: Lakshmi, Sowmya P., et al.
Publicado: (2017)

Obesity and the microbiome in atopic dermatitis: Therapeutic implications for PPAR-γ agonists
por: McAleer, Jeremy P.
Publicado: (2023)

PPARγ Agonist Beyond Glucose Lowering Effect
por: Sugawara, Akira, et al.
Publicado: (2011)

Astrocytic Glutamatergic Transmission and Its Implications in Neurodegenerative Disorders
por: Satarker, Sairaj, et al.
Publicado: (2022)

Regulation of Immune Cell Function by PPARs and the Connection with Metabolic and Neurodegenerative Diseases
por: Le Menn, Gwenaëlle, et al.
Publicado: (2018)

The Role of PPARs in the Endothelium: Implications for Cancer Therapy
por: Bishop-Bailey, David, et al.
Publicado: (2008)

Role of FET proteins in neurodegenerative disorders
por: Svetoni, Francesca, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_i2tr2g1frj8jj95dek2kaahla9